Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
PUT
Corning
GLW
$119B
| $205K | ﹤0.01% |
5,000
| – | – |
|
3502
CRA International
CRAI
$1.16B
| $204K | ﹤0.01% |
2,387
-3,912
| -62% | -$318K |
|
3503
Invesco Semiconductors ETF
PSI
$2.34B
| $204K | ﹤0.01% |
4,755
+1,164
| +32% | +$47.4K |
|
3504
Peapack-Gladstone Financial
PGC
$815M
| $202K | ﹤0.01% |
6,540
-12,823
| -66% | -$414K |
|
3505
Impinj
PI
$4.62B
| $202K | ﹤0.01% |
3,922
-10,410
| -73% | -$536K |
|
3506
Senseonics Holdings Inc
SENS
$263M
| $202K | ﹤0.01% |
2,628
+1,371
| +109% | +$69.4K |
|
|
MGI
3507
DELISTED
MoneyGram International, Inc. New
MGI
| $201K | ﹤0.01% |
19,865
-31,984
| -62% | -$270K |
|
3508
National CineMedia
NCMI
$376M
| $200K | ﹤0.01% |
3,970
-1,245
| -24% | -$58.4K |
|
3509
Schwab US Mid-Cap ETF
SCHM
$14.7B
| $200K | ﹤0.01% |
+7,659
| New | +$198K |
|
3510
Aemetis
AMTX
$106M
| $199K | ﹤0.01% |
+17,841
| New | +$281K |
|
3511
Cars.com
CARS
$662M
| $199K | ﹤0.01% |
13,886
-150,350
| -92% | -$2.09M |
|
3512
Mercer International
MERC
$42.3M
| $199K | ﹤0.01% |
15,660
-702
| -4% | -$10.4K |
|
3513
IQ ARB Merger Arbitrage ETF
MNA
$252M
| $199K | ﹤0.01% |
+5,938
| New | +$199K |
|
3514
NRC Health Common Stock
NRC
$432M
| $199K | ﹤0.01% |
4,345
-9,328
| -68% | -$444K |
|
3515
Element Solutions
ESI
$8.95B
| $198K | ﹤0.01% |
8,478
-121,763
| -93% | -$2.68M |
|
3516
VEON
VEON
$3.62B
| $198K | ﹤0.01% |
4,320
-5,451
| -56% | -$241K |
|
|
SILV
3517
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $198K | ﹤0.01% |
22,700
+309
| +1% | +$2.83K |
|
|
AMJ
3518
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $198K | ﹤0.01% |
10,052
| – | – |
|
|
CNCE
3519
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $198K | ﹤0.01% |
47,035
-21,365
| -31% | -$90.4K |
|
3520
Allot
ALLT
$372M
| $197K | ﹤0.01% |
+9,958
| New | +$183K |
|
|
ITIC
3521
Investors Title Co
ITIC
$546M
| $197K | ﹤0.01% |
1,126
-831
| -42% | -$145K |
|
3522
PUT
3D Systems Corp
DDD
$431M
| $196K | ﹤0.01% |
4,900
-400
| -8% | -$10.6K |
|
3523
CALL
Fluor
FLR
$7.01B
| $196K | ﹤0.01% |
11,100
-249,000
| -96% | -$5.13M |
|
3524
Forestar Group
FOR
$1.44B
| $196K | ﹤0.01% |
9,375
-5,118
| -35% | -$120K |
|
|
SPNS
3525
DELISTED
Sapiens International
SPNS
| $196K | ﹤0.01% |
7,442
-16,571
| -69% | -$489K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.